Breaking News

QS Pharma Gains EMA Approval for Commercial Manufacture 

Boothwyn, PA facility to manufacture certain medicinal products for commercial use in Europe

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

QS Pharma, the contract development and manufacturing organization acquired by Quotient Clinical in February 2017, has received approval from the European Medicines Agency (EMA) to manufacture certain medicinal products for commercial use in Europe.   QS Pharma’s manufacturing facility in Boothwyn, PA, was inspected in February 2017 by the Dutch Health Care Inspectorate (IGZ) at the request of the EMA. The assessment focused on two NDA filed products, and the overall quality systems of QS Phar...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters